Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Arix Bioscience plc
  6. News
  7. Summary
    ARIX   GB00BD045071

ARIX BIOSCIENCE PLC

(ARIX)
  Report
Delayed Quote. Delayed London Stock Exchange - 10/20 11:35:21 am
139 GBX   -0.36%
10/18LogicBio Therapeutics Announces Early Clinical -2-
DJ
10/18ARIX BIOSCIENCE : Cancels Share Repurchase Program to Focus on Investments
MT
10/18Business Update and Cancellation of Share Buyback
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Total Voting Rights

09/01/2021 | 02:01am EDT

Arix Bioscience PLC (ARIX) Total Voting Rights 01-Sep-2021 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

Arix Bioscience plc

Total Voting Rights

In conformity with 5.6.1R of the Disclosure Guidance and Transparency Rules, Arix Bioscience plc announces that its total issued share capital at the close of business on 31 August 2021 comprised 135,609,653 Ordinary Shares of 0.001 pence each fully paid. This figure includes 5,153,853 Ordinary Shares which are held in Treasury, leaving a balance of 130,455,800 Ordinary Shares with voting rights.

The above figure of 130,455,800 may be used by shareholders for the calculations by which they will determine if they are required to notify their major interest in, or a change to their major interest in, Arix Bioscience plc under the Disclosure Guidance and Transparency Rules.

[ENDS]

For further information, please contact:

Arix Bioscience plc

+44 (0)20 7290 1050

ir@arixbioscience.com

-----------------------------------------------------------------------------------------------------------------------

ISIN:           GB00BD045071 
Category Code:  TVR 
TIDM:           ARIX 
LEI Code:       213800OVT3AHQCXNIX43 
OAM Categories: 2.5. Total number of voting rights and capital 
Sequence No.:   121167 
EQS News ID:    1230243 
 
End of Announcement  EQS News Service 
=------------------------------------------------------------------------------------
 

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1230243&application_name=news

(END) Dow Jones Newswires

September 01, 2021 02:00 ET (06:00 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
ARIX BIOSCIENCE PLC -0.36% 139 Delayed Quote.-36.30%
DJ INDUSTRIAL 0.43% 35609.34 Delayed Quote.15.20%
All news about ARIX BIOSCIENCE PLC
10/18LogicBio Therapeutics Announces Early Clinical -2-
DJ
10/18ARIX BIOSCIENCE : Cancels Share Repurchase Program to Focus on Investments
MT
10/18Business Update and Cancellation of Share Buyback
DJ
10/18Tranche Update on Arix Bioscience plc's Equity Buyback Plan announced on March 15, 2021..
CI
10/18Arix Bioscience plc's Equity Buyback announced on March 15, 2021, has expired with 6,42..
CI
10/15Transaction in own shares
DJ
10/13Transaction in own shares
DJ
10/13TR1 : Notification of Major Shareholding -2-
DJ
10/13TR1 : Notification of Major Shareholding
DJ
10/12ARIX BIOSCIENCE : Investee Aura Biosciences Posts Interim Data from Choroidal Melanoma Dru..
MT
More news
Financials
Sales 2021 - - -
Net income 2021 - - -
Net cash 2021 133 M 184 M 184 M
P/E ratio 2021 -
Yield 2021 -
Capitalization 172 M 238 M 238 M
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees 12
Free-Float 72,1%
Chart ARIX BIOSCIENCE PLC
Duration : Period :
Arix Bioscience plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ARIX BIOSCIENCE PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 1,39 GBX
Average target price 256,00 GBX
Spread / Average Target 18 317%
EPS Revisions
Managers and Directors
Robert William Henry Lyne CEO, COO, Secretary, Director & General Counsel
Marcus Karia Group Finance Director
Peregrine D. E. M. Moncreiffe Non-Executive Chairman
Graeme Smith Chief Technology Officer
Michael William Bunbury Senior Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ARIX BIOSCIENCE PLC-36.30%239
INVESTOR AB (PUBL)32.42%70 282
CK HUTCHISON HOLDINGS LIMITED-1.57%26 295
GROUPE BRUXELLES LAMBERT SA20.00%17 487
HAL TRUST29.70%15 069
AB INDUSTRIVÄRDEN (PUBL)3.14%14 164